Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method for amorphous form of canagliflozin

A canagliflozin and amorphous technology, applied in the field of medicinal chemistry, can solve problems such as high equipment requirements, high industrialization costs, and difficulty in control, and achieve the effects of good fluidity, easy recovery, and low product loss

Inactive Publication Date: 2017-04-26
ZHEJIANG HUAHAI PHARMA CO LTD
View PDF10 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, canagliflozin amorphous preparation adopts methods such as melting and solidification, mixed solvent elution crystallization, spray drying or direct distillation. These methods have high industrialization costs, high equipment requirements, and are difficult to control

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for amorphous form of canagliflozin
  • Preparation method for amorphous form of canagliflozin
  • Preparation method for amorphous form of canagliflozin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Add 20 g of canagliflozin and 60 ml of ethyl acetate into the reaction bottle, stir at a temperature of 35-45°C until it dissolves, and then distill under reduced pressure at a temperature of 35-45°C to a residual weight of 21.0 g to obtain an oily substance. Add 100ml of n-heptane dropwise to the reaction bottle, after the dropwise addition, keep the temperature at 10-20°C for 2 hours. After the heat preservation was completed, the temperature was lowered to 0°C, filtered, and the filter cake was vacuum-dried at 20°C, and discharged to obtain 19.2 g of canagliflozin amorphous as a white powdery solid with a yield of 96.0%. The ethyl acetate recovered by distillation and the n-heptane in the mother liquor can be used directly after simple water removal.

[0050] figure 1 It is the X-ray powder diffraction pattern of the canagliflozin amorphous that embodiment 1 obtains, from figure 1 It can be seen that the diffraction pattern is a typical amorphous substance.

[005...

Embodiment 2

[0055] Add 20 g of canagliflozin and 20 ml of ethyl acetate to the reaction bottle, stir at a temperature of 60-70°C until it dissolves, and then distill under reduced pressure at a temperature of 75-85°C to a residual weight of 21.2g to obtain an oily substance. Add 80 ml of cyclohexane dropwise to the reaction bottle, after the dropwise addition is completed, keep the temperature at 20-30°C for 2 hours. After the heat preservation was completed, the temperature was lowered to 5° C., filtered, and the filter cake was vacuum-dried at 30° C., and discharged to obtain 19.1 g of canagliflozin amorphous as a white powdery solid with a yield of 95.5%.

Embodiment 3

[0057] Add 20 g of canagliflozin and 20 ml of ethanol to the reaction bottle, stir at a temperature of 65-70°C until it dissolves, and then distill under reduced pressure at a temperature of 45-55°C to a residual weight of 22.0g to obtain an oily substance. Add 60 ml of cyclohexane dropwise to the reaction bottle, after the dropwise addition is complete, keep the temperature at 15-25°C for 2 hours. After heat preservation was completed, the temperature was lowered to 10°C, filtered, the filter cake was dried at 30°C, and discharged to obtain 19.4 g of canagliflozin amorphous as a white powdery solid with a yield of 97.0%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a preparation method for the amorphous form of canagliflozin. The preparation method comprises: adding canagliflozin to an organic solvent, dissolving, and distilling to achieve a certain mass of an oil-like substance; and adding an anti-solvent to the oil-like substance, stirring to precipitate a solid, cooling, filtering, and drying to obtain the amorphous form of canagliflozin. According to the present invention, the preparation method has characteristics of low solvent rate, high yield, simple operation, easy recovery, less three-waste, good reproducibility, stable product quality, good product flowability, and the like, is suitable for preparation production and commercialize large-scale production, and has high promotion and application values.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a method for preparing amorphous canagliflozin. Background technique [0002] Canagliflozin, chemical name (1S)-1,5-dehydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4 -Methylphenyl]-D-glucitol, its chemical structural formula is: [0003] [0004] Canagliflozin is a selective type 2 sodium glucose co-transporter (SGLT2) inhibitor developed by Johnson & Johnson in the United States. It is mainly used for the treatment of type II diabetic patients who are ineffective through exercise or diet control. In March 2013, it was approved by the FDA to go on the market in the United States. This product can lower blood sugar by decomposing glucose and excreting it through the kidneys. In addition to good blood sugar control, canagliflozin is most notable for weight loss and few hypoglycemic events, and has a very broad prospect. [0005] In recent years, there have been report...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D409/10
CPCC07D409/10C07H7/06
Inventor 钱刚周燕宝张林祥张文灵
Owner ZHEJIANG HUAHAI PHARMA CO LTD